Skip to main content
Top
Published in: Diabetologia 1/2018

01-01-2018 | Commentary

When beta cells talk back

Authors: Heather C. Denroche, Dominika Nackiewicz, C. Bruce Verchere

Published in: Diabetologia | Issue 1/2018

Login to get access

Excerpt

Islet macrophages reside in the perivascular space next to islet blood vessels. They are long-lived and self-renewing, maintaining about two to ten macrophages per islet [1]. However, more than three decades after the first description of islet macrophages [2], our knowledge regarding the biological role of these cells is limited (reviewed in [3]). Emerging evidence indicates that islet macrophages are important for islet homeostasis and secrete numerous factors that modulate beta cell activity. Reciprocally, in this issue of Diabetologia, Weitz et al demonstrate that a factor secreted by beta cells is sensed by islet macrophages [4], revealing the possibility of a physiological, two-way dialogue between islet macrophages and pancreatic beta cells (Fig. 1).
Literature
1.
go back to reference Calderon B, Carrero JA, Ferris ST et al (2015) The pancreas anatomy conditions the origin and properties of resident macrophages. J Exp Med 212:1497–1512CrossRefPubMedPubMedCentral Calderon B, Carrero JA, Ferris ST et al (2015) The pancreas anatomy conditions the origin and properties of resident macrophages. J Exp Med 212:1497–1512CrossRefPubMedPubMedCentral
2.
go back to reference Hume DA, Halpin D, Charlton H, Gordon S (1984) The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of endocrine organs. Proc Natl Acad Sci 81:4174–4177CrossRefPubMedPubMedCentral Hume DA, Halpin D, Charlton H, Gordon S (1984) The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of endocrine organs. Proc Natl Acad Sci 81:4174–4177CrossRefPubMedPubMedCentral
5.
go back to reference Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370CrossRefPubMed Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370CrossRefPubMed
6.
go back to reference Böni-Schnetzler M, Thorne J, Parnaud G et al (2008) Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93:4065–4074CrossRefPubMedPubMedCentral Böni-Schnetzler M, Thorne J, Parnaud G et al (2008) Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93:4065–4074CrossRefPubMedPubMedCentral
7.
go back to reference Nackiewicz D, Dan M, He W et al (2014) TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6. Diabetologia 57:1645–1654CrossRefPubMed Nackiewicz D, Dan M, He W et al (2014) TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6. Diabetologia 57:1645–1654CrossRefPubMed
8.
go back to reference Westwell-Roper C, Dai DL, Soukhatcheva G et al (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 187:2755–2765CrossRefPubMed Westwell-Roper C, Dai DL, Soukhatcheva G et al (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 187:2755–2765CrossRefPubMed
9.
go back to reference Masters SL, Dunne A, Subramanian SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 11:897–904CrossRefPubMedPubMedCentral Masters SL, Dunne A, Subramanian SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 11:897–904CrossRefPubMedPubMedCentral
10.
11.
go back to reference Jourdan T, Godlewski G, Cinar R et al (2013) Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med 19:1132–1140CrossRefPubMedPubMedCentral Jourdan T, Godlewski G, Cinar R et al (2013) Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med 19:1132–1140CrossRefPubMedPubMedCentral
12.
go back to reference Westwell-Roper CY, Ehses JA, Verchere CB (2014) Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction. Diabetes 63:1698–1711CrossRefPubMed Westwell-Roper CY, Ehses JA, Verchere CB (2014) Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction. Diabetes 63:1698–1711CrossRefPubMed
13.
go back to reference Calderon B, Suri A, Unanue ER (2006) In CD4+ T cell-induced diabetes, macrophages are the final effector cells that mediate islet β-cell killing. Am J Pathol 169:2137–2147CrossRefPubMedPubMedCentral Calderon B, Suri A, Unanue ER (2006) In CD4+ T cell-induced diabetes, macrophages are the final effector cells that mediate islet β-cell killing. Am J Pathol 169:2137–2147CrossRefPubMedPubMedCentral
14.
go back to reference Kolb H, Burkart V, Appels B et al (1990) Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J Autoimmun 3(Suppl 1):117–120CrossRefPubMed Kolb H, Burkart V, Appels B et al (1990) Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J Autoimmun 3(Suppl 1):117–120CrossRefPubMed
15.
go back to reference Hajmrle C, Smith N, Spigelman AF et al (2016) Interleukin-1 signaling contributes to acute islet compensation. JCI Insight 1:1–14CrossRef Hajmrle C, Smith N, Spigelman AF et al (2016) Interleukin-1 signaling contributes to acute islet compensation. JCI Insight 1:1–14CrossRef
16.
go back to reference Dror E, Dalmas E, Meier DT et al (2017) Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol 18:283–292CrossRefPubMed Dror E, Dalmas E, Meier DT et al (2017) Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol 18:283–292CrossRefPubMed
17.
go back to reference Vomund AN, Zinselmeyer BH, Hughes J et al (2015) Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells. Proc Natl Acad Sci U S A 112:E5496–E5502CrossRefPubMedPubMedCentral Vomund AN, Zinselmeyer BH, Hughes J et al (2015) Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells. Proc Natl Acad Sci U S A 112:E5496–E5502CrossRefPubMedPubMedCentral
18.
go back to reference Banaei-Bouchareb L, Gouon-Evans V, Samara-Boustani D et al (2004) Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. J Leukoc Biol 76:359–367CrossRefPubMed Banaei-Bouchareb L, Gouon-Evans V, Samara-Boustani D et al (2004) Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. J Leukoc Biol 76:359–367CrossRefPubMed
19.
go back to reference Brissova M, Aamodt K, Brahmachary P et al (2014) Islet microenvironment,modulated by vascular endothelial growth factor-A signaling, promotes beta cell regeneration. Cell Metab 19:498–511 Brissova M, Aamodt K, Brahmachary P et al (2014) Islet microenvironment,modulated by vascular endothelial growth factor-A signaling, promotes beta cell regeneration. Cell Metab 19:498–511
20.
21.
go back to reference Xiao X, Gaffar I, Guo P et al (2014) M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A 111:E1211–E1220CrossRefPubMedPubMedCentral Xiao X, Gaffar I, Guo P et al (2014) M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A 111:E1211–E1220CrossRefPubMedPubMedCentral
22.
23.
go back to reference Jacob F, Novo CP, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:285–306CrossRefPubMedPubMedCentral Jacob F, Novo CP, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:285–306CrossRefPubMedPubMedCentral
24.
go back to reference Wang L, Jacobsen SEW, Bengtsson A, Erlinge D (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5:16CrossRefPubMedPubMedCentral Wang L, Jacobsen SEW, Bengtsson A, Erlinge D (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5:16CrossRefPubMedPubMedCentral
26.
go back to reference Gu BJ, Wiley JS (2006) Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107:4946–4953CrossRefPubMed Gu BJ, Wiley JS (2006) Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107:4946–4953CrossRefPubMed
27.
go back to reference Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Plegrín P (2012) P2X7 receptor-stimulation causes fever via PGE2 and IL-1 release. FASEB J 26:2951–2962CrossRefPubMed Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Plegrín P (2012) P2X7 receptor-stimulation causes fever via PGE2 and IL-1 release. FASEB J 26:2951–2962CrossRefPubMed
28.
go back to reference Kawano A, Tsukimoto M, Mori D et al (2012) Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages. Biochem Biophys Res Commun 420:102–107CrossRefPubMed Kawano A, Tsukimoto M, Mori D et al (2012) Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages. Biochem Biophys Res Commun 420:102–107CrossRefPubMed
29.
go back to reference Idzko M, Hammad H, van Nimwegen M et al (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13:913–919CrossRefPubMed Idzko M, Hammad H, van Nimwegen M et al (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13:913–919CrossRefPubMed
30.
go back to reference Elliott MR, Chekeni FB, Trampont PC et al (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282–286CrossRefPubMedPubMedCentral Elliott MR, Chekeni FB, Trampont PC et al (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282–286CrossRefPubMedPubMedCentral
Metadata
Title
When beta cells talk back
Authors
Heather C. Denroche
Dominika Nackiewicz
C. Bruce Verchere
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4443-8

Other articles of this Issue 1/2018

Diabetologia 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.